Biomedical Engineering Reference
In-Depth Information
11.4
Conclusions and Future Directions
Though much innovation continues to drive the development of naturally renewable
materials for bone tissue engineering, much controversy exists as to which materials
exhibit paramount in vivo evidence for direct clinical significance. One of the principle
issues remaining to be addressed is the understanding why some systems allow and/or
promote calcification and skeletal integration while others do not. The combination of
MSCs and growth factors, notably BMP-2, seem to be the current status quo for promot-
ing bone formation in vivo . Work has largely focused on varying the material or carrier
in use. Overall, when choosing which natural material should be used for bone tissue
engineering, one must keep in mind the anatomical location of the defect, i.e. whether
it is a loadbearing or nonloadbearing site, as this will greatly limit the application of
most gelatinous systems that are unable to withstand physiological loading forces for
that defect site. Composite systems of inorganic and organic components have become
popular and a recent review discusses some in use (139). In Vivo work has focused
on examining implanted materials via histology and quantifying radio-opacity compared
to bone controls. These techniques offer merely a glance at what has been achieved
and require more detailed investigatory work before worldwide clinical acceptance. For
instance, few implanted tissue constructs have been examined for the osteogenic proper-
ties of bone such as the organization of osteons or formation of haversian canal systems.
Though much progress has been made, bone tissue engineering is still in its infancy, as
specialized materials are being developed and analyzed for skeletal regeneration.
References
1.
Fung YC. Biomechanics: Motion, Flow, Stress, and Growth . New York: Springer-
Verlag; 1990.
2.
Mow VC, Hayes WC, editors. Basic Orthopaedic Biomechanics . 2nd ed. Philadel-
phia: Lippincott-Raven; 1997.
3.
Afizah H, Yang Z, Hui JH, Ouyang HW, Lee EH. A comparison between the
chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-
derived stem cells (ADSCs) taken from the same donors. Tissue Eng . 2007 Apr;
13(4):659-66.
4.
Bignon A, Chouteau J, Chevalier J et al . Effect of micro- and macroporosity of
bone substitutes on their mechanical properties and cellular response. J Mater Sci
Mater Med . 2003 Dec;14(12):1089-97.
5.
Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineer-
ing. Biomaterials . 2000 Dec;21(23):2347-59.
6.
Cornell CN. Osteoconductive materials and their role as substitutes for autogenous
bone grafts. Orthop Clin North Am . 1999 Oct;30(4):591-8.
7.
Kon E, Muraglia A, Corsi A et al . Autologous bone marrow stromal cells loaded
onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects
of sheep long bones. JBiomedMaterRes . 2000 Mar 5;49(3):328-37.
Search WWH ::




Custom Search